This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: other/unspecified salivary gland
CD2_BENIGN_SALIVARY_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: other/unspecified salivary gland
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: other/unspecified salivary gland
- Benign neoplasm of major salivary glands
- Benign neoplasm of major salivary glands
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 993 | 541 | 452 |
| Unadjusted period prevalence (%) | 0.19 | 0.18 | 0.20 |
| Median age at first event (years) | 51.51 | 48.48 | 55.14 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 899
- Matched controls
- 8989
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D11.70
ICD-10 Finland
Gland sublingual
+∞
323.0
345
*
ELB30
NOMESCO Finland
Excision of submandibular gland
283.4
236.4
232
11
2102A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Major salivary glands
+∞
235.0
215
*
21020
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Salivary gland
+∞
222.3
204
*
4405
FHL
Partial removal of the parotid gland
1673.5
149.3
141
*
D11.9
ICD-10 Finland
Benign neoplasm: Major salivary gland, unspecified
+∞
135.9
127
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
31.9
105.6
141
52
EP1AE
NOMESCO Finland
Neck ultrasound examination
11.1
69.1
137
143
130
Kela drug reimbursment
Malignant tumour
+∞
67.5
64
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
12.6
67.3
125
114
C61
ICD-10 Finland
Malignant neoplasm of prostate
287.5
53.8
54
*
H02AB02
ATC
dexamethasone; systemic
25.1
51.0
72
31
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
50.5
48
*
ELB40
NOMESCO Finland
Partial parotidectomy
24.0
48.3
69
31
115
Kela drug reimbursment
Breast cancer
+∞
47.3
45
*
D11.7
ICD-10 Finland
Benign neoplasm: Other major salivary glands
+∞
43.1
41
*
PJA12
NOMESCO Finland
Sentinel node biopsy
404.2
39.4
39
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
37.8
36
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
132.0
36.0
38
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
45.0
35.3
43
10
WF003
NOMESCO Finland
Adjuvant radiotherapy
349.6
34.1
34
*
A04AA02
ATC
granisetron; systemic, transdermal
79.3
34.1
38
5
4404
FHL
Complete removal of the parotid gland
181.8
34.0
35
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
32.5
31
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
38.0
26.3
33
9
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
25.6
249
1203
A03FA01
ATC
metoclopramide; systemic, rectal
3.2
25.5
150
532
K11.2
ICD-10 Finland
Sialoadenitis
6.8
25.2
65
102
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
40.1
25.0
31
8
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
24.1
23
*
116
Kela drug reimbursment
Prostate cancer
+∞
24.1
23
*
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
89.2
23.8
26
*
WF002
NOMESCO Finland
Radical radiotherapy
55.5
23.2
27
5
L03AA13
ATC
pegfilgrastim; parenteral
235.6
22.7
23
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
18.5
22.3
34
19
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
22.0
21
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
22.0
21
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
20.9
20
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
20.9
20
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
214.7
20.7
21
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
214.7
20.7
21
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
19.9
19
*
4403
FHL
Submandibular gland removal
75.2
19.8
22
*
JN4AD
NOMESCO Finland
Body CT examination
5.4
19.7
60
117
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
18.8
18
*
L02BA01
ATC
tamoxifen; oral
193.8
18.6
19
*
JN4BD
NOMESCO Finland
Extensive body CT
4.1
18.3
74
194
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
22.3
18.2
26
12
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
8.0
18.2
41
53
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.2
17.9
40
51
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
17.8
17
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
17.8
17
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
17.8
17
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
17.8
17
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
17.8
17
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
183.4
17.6
18
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.7
17.4
60
135
WX402
NOMESCO Finland
General anaesthesia
2.7
17.2
131
542
HAC20
NOMESCO Finland
Total mastectomy
51.0
17.0
20
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
16.7
16
*
C08.09
ICD-10 Finland
Malignant tumor of the submandibular or submaxillary gland, other or unspecified histology
+∞
16.7
16
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
16.7
16
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
16.7
16
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.5
16.5
24
12
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
25.0
16.1
22
9
D11.71
ICD-10 Finland
Gland submandibular
+∞
15.7
15
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
15.7
15
*
L03AA02
ATC
filgrastim; parenteral
26.8
15.6
21
8
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
57.6
14.8
17
*
HA1AA
NOMESCO Finland
X-ray mammography
5.2
14.8
46
93
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
21.5
14.7
21
10
L02BG04
ATC
letrozole; oral
12.1
14.6
26
22
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
14.6
14
*
L01BC06
ATC
capecitabine; oral
+∞
14.6
14
*
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
11.1
14.6
27
25
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
43.2
14.1
17
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
13.8
220
1276
XX3DW
NOMESCO Finland
Time consuming IT work
3.7
13.7
61
175
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
13.6
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.6
13
*
Z51.5
ICD-10 Finland
Palliative care
5.3
13.3
40
78
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.6
13.3
38
70
ZXA00
NOMESCO Finland
Right side
1.9
13.3
246
1508
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
11.2
13.1
24
22
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.6
13.0
37
68
ELB50
NOMESCO Finland
Total parotidectomy
50.7
12.9
15
*
A04AA01
ATC
ondansetron; systemic, rectal
5.2
12.7
39
78
L02BB03
ATC
bicalutamide; oral
+∞
12.5
12
*
L02BG03
ATC
anastrozole; oral
+∞
12.5
12
*
A04AD12
ATC
aprepitant; systemic
131.7
12.5
13
*
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
27.1
12.1
16
6
ZXA05
NOMESCO Finland
Left side
1.8
11.8
231
1433
KCD02
NOMESCO Finland
Transurethral resection of bladder
16.7
11.7
18
11
4704
FHL
Neck tumor removal
65.8
11.6
13
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
19.2
11.6
17
9
C50.99
ICD-10 Finland
Breast, unspecified
+∞
11.5
11
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
11.5
11
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
11.5
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.5
11
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
11.5
11
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
11.5
11
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
11.5
11
*
C50
ICD-10 Finland
Malignant neoplasm of breast
121.4
11.4
12
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
35.5
11.3
14
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
20.3
11.2
16
8
K11.9
ICD-10 Finland
Disease of salivary gland, unspecified
14.1
11.0
18
13
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
9.0
10.8
22
25
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
18.1
10.7
16
9
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
111.2
10.4
11
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
10.4
10
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
10.4
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.4
10
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
10.4
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.4
10
*
C08.00
ICD-10 Finland
Malignant tumor of submandibular or submaxillary gland, not histology
+∞
10.4
10
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
10.4
10
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
10.4
10
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
10.4
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.4
10
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
9.6
89
409
N02AA05
ATC
oxycodone; systemic
2.1
9.6
109
548
L02AE02
ATC
leuprorelin; implant, parenteral
11.5
9.6
17
15
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
101.0
9.4
10
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
17.7
9.4
14
8
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.4
9
*
X76
ICPC
Malignant neoplasm breast female
+∞
9.4
9
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
9.4
9
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
37.1
9.0
11
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
37.1
9.0
11
*
A02BC02
ATC
pantoprazole; systemic
1.5
8.9
531
4354
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
50.5
8.7
10
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
7.7
8.7
19
25
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.7
8.7
28
61
4402
FHL
Removal or exploration of a salivary change (eg ranula)
90.8
8.4
9
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
90.8
8.4
9
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
12.9
8.4
14
11
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.3
8
*
L02BG06
ATC
exemestane; oral
+∞
8.3
8
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
8.3
8
*
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
+∞
8.3
8
*
C08.02
ICD-10 Finland
Cystic adenocarcinoma of the submandibular or submaxillary glands
+∞
8.3
8
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
8.3
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
22.2
8.0
11
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.0
136
799
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.0
7.7
29
74
S18
ICPC
Laceration/cut
1.5
7.6
320
2396
JN6AD
NOMESCO Finland
CT of torso and neck
18.5
7.6
11
6
4701
FHL
Neck lymph node removal
25.2
7.6
10
*
A79
ICPC
Malignancy NOS
25.2
7.6
10
*
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
7.6
316
2362
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
80.7
7.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
80.7
7.4
8
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
13.5
7.4
12
9
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
7.3
7
*
8200/3-C08.0
ICD-O-3
Adenoid cystic carcinoma of submandibular gland
+∞
7.3
7
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
7.3
7
*
WW500
NOMESCO Finland
Blood transfusion
4.3
7.1
25
60
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
8.9
7.1
14
16
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
8.9
7.1
14
16
J01DB01
ATC
cefalexin; oral
1.5
7.0
653
5737
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.2
7.0
20
39
B01AB10
ATC
tinzaparin; parenteral
2.7
6.8
45
175
S04
ICPC
Lump/swelling localized
2.1
6.8
72
355
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.2
6.7
15
21
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
6.7
62
288
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
70.3
6.4
7
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
70.3
6.4
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
70.3
6.4
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
70.3
6.4
7
*
ELB99
NOMESCO Finland
Other excision of salivary gland
70.3
6.4
7
*
4409
FHL
Other measure in this category
70.3
6.4
7
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
6.3
64
309
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
6.3
336
2622
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
6.3
6
*
8430/3-C08.0
ICD-O-3
Mucoepidermoid carcinoma of submandibular gland
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
6.3
6
*
TQW20
NOMESCO Finland
Tatoe
+∞
6.3
6
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
6.3
6
*
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
6.3
6
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
6.3
6
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
6.3
6
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
26.9
6.2
8
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.6
6.2
41
160
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.9
6.1
18
37
WZC30
NOMESCO Finland
Teaching
2.0
6.0
75
394
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
129
104
14.11
134.20
1.3
1.2
—
—
—
0
0
113
397
3.08
24.76
3.2
1.5
11.7
3.6
ug/l
1.00
94
310
541
3961
1.80
18.15
9.3
6.3
4.2
4.3
e9/l
0.27
479
3426
144
729
2.14
14.46
3.8
3.0
250.4
235.3
u/l
0.53
133
686
18
6
30.51
13.91
1.3
1.2
—
—
—
0
0
485
3633
1.65
13.41
6.3
3.7
10.8
11.8
umol/l
2.00
461
3385
428
3193
1.60
11.44
5.2
3.7
35.0
35.5
g/l
1.05
405
2936
479
3732
1.55
10.22
8.1
5.3
1.2
1.2
mmol/l
0.35
409
3164
418
3220
1.51
9.05
4.6
3.6
—
—
—
0
0
667
5700
1.52
8.49
8.3
5.4
81.3
76.1
u/l
1.48
624
5237
169
1068
1.70
8.40
3.3
2.4
0.8
0.8
mmol/l
0.91
159
980
430
3371
1.49
8.35
6.8
4.8
1.2
1.2
mmol/l
0.28
390
2984
324
2448
1.48
7.34
3.5
2.0
2.3
2.4
mmol/l
0.92
285
2030
309
2338
1.47
6.87
2.6
2.2
56.9
57.5
u/l
0.07
286
2123
276
2050
1.48
6.72
3.1
2.9
0.3
0.4
e6/l
1.83
212
1558
227
1625
1.51
6.60
2.2
2.0
—
—
—
0
0
16
38
4.26
6.30
1.7
1.3
37.0
15.1
ug/l
1.16
16
38
146
956
1.62
6.26
6.4
4.4
1.0
1.0
mmol/l
0.07
138
867
585
5026
1.40
6.14
4.9
4.5
1281.6
1980.5
e6/l
—
9
78
136
895
1.60
5.70
5.7
5.5
104.5
104.4
mmol/l
0.16
127
871
180
1265
1.52
5.65
2.7
2.5
1.1
1.5
e6/l
0.61
116
740
12
25
4.85
5.50
1.1
1.0
—
—
—
0
0
526
4524
1.35
5.03
5.3
4.1
7.0
6.8
mmol/l
1.24
499
4221
53
278
1.96
4.87
2.5
1.7
4.4
2.1
ug/l
0.37
48
247
163
1161
1.48
4.76
2.8
2.7
2.4
2.9
e6/l
0.33
100
638
210
1579
1.42
4.60
2.7
2.4
6.1
5.6
e6/l
0.24
177
1375
12
30
4.04
4.44
1.0
1.3
—
—
—
0
0
12
30
4.04
4.44
4.3
1.6
2.6
3.7
nmol/l
0.60
12
30
93
604
1.60
4.14
9.6
6.1
10.4
10.6
mmol/l
0.09
86
571
125
875
1.49
3.98
7.0
5.8
11.7
11.5
kpa
0.15
118
837
125
875
1.49
3.98
7.0
5.8
5.0
5.1
kpa
1.04
117
837
107
725
1.53
3.97
4.4
3.0
2.2
2.1
mmol/l
0.13
89
585
147
1065
1.45
3.93
3.0
2.3
2.3
2.3
g/l
0.65
134
984
10
24
4.20
3.89
2.2
2.6
—
—
—
0
0
10
24
4.20
3.89
2.2
2.6
—
—
—
0
0
125
880
1.48
3.87
7.0
5.8
1.9
1.4
mmol/l
0.60
95
680
159
1173
1.42
3.85
3.1
2.3
11.5
13.2
umol/l
2.30
145
1076
94
628
1.55
3.72
2.0
1.6
65.7
67.1
g/l
1.05
89
565
277
2249
1.32
3.67
3.4
2.6
33.1
32.9
u/l
0.03
261
2129
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
216
1.89
3.45
2.9
2.5
0.4
0.4
u/ml
0.00
22
134
187
1446
1.36
3.42
3.4
2.1
2.5
2.4
mmol/l
0.59
167
1239
40
218
1.87
3.36
2.9
1.3
1.4
1.2
ratio
—
6
22
41
226
1.85
3.33
2.9
1.4
91.9
46.7
mg/l
0.62
35
184
33
169
1.99
3.32
4.8
2.9
7.8
8.0
kpa
0.29
33
155
61
378
1.65
3.31
6.4
3.2
48.8
48.4
%
0.04
61
372
41
228
1.83
3.24
2.9
1.4
36.7
36.1
mg/l
0.04
35
186
133
981
1.41
3.23
3.3
2.4
19.9
23.1
%
1.97
117
831
51
304
1.71
3.21
1.8
2.1
36.5
38.9
u/l
0.39
44
264
34
180
1.92
3.13
1.8
1.6
—
—
—
0
0
29
149
1.97
2.92
2.9
2.4
16.1
16.5
%
0.13
17
76
25
122
2.08
2.89
1.2
1.4
—
—
—
0
0
9
22
4.12
2.88
3.3
1.9
—
—
—
0
0
87
606
1.48
2.88
2.8
2.3
68.3
63.3
ml/min/173m2
0.47
38
255
43
253
1.73
2.86
3.5
4.1
3.9
3.9
mmol/l
0.15
34
236
91
641
1.46
2.84
2.1
2.1
33.2
36.7
u/l
0.38
77
523
20
91
2.22
2.75
1.3
1.3
—
—
—
0
0
99
717
1.42
2.68
7.1
6.4
119.3
121.2
g/l
0.43
93
696
664
6147
1.24
2.63
22.8
15.6
13.9
13.7
%
2.39
651
5975
23
113
2.06
2.63
1.2
1.3
—
—
—
0
0
75
518
1.48
2.60
9.7
6.3
24.8
24.6
mmol/l
0.12
67
488
145
1126
1.34
2.58
28.7
27.0
1.4
1.4
inr
0.16
31
158
106
784
1.39
2.56
3.5
3.0
—
—
—
0
0
714
6675
1.25
2.53
19.6
14.4
38.8
39.3
%
0.56
490
4384
360
3138
1.23
2.51
3.4
2.7
128.3
123.8
ug/l
0.16
330
2867
68
465
1.50
2.49
4.2
3.3
2.7
1.9
mmol/l
0.98
49
355
87
627
1.42
2.44
4.7
3.5
98.5
89.7
ng/l
0.38
73
539
425
3778
1.22
2.43
4.3
3.7
0.0
0.0
estimate
0.80
69
629
12
46
2.63
2.36
1.0
1.1
—
—
—
0
0
71
497
1.46
2.33
1.7
1.5
—
—
—
0
0
16
72
2.24
2.28
1.3
2.1
—
552.4
—
0
9
49
319
1.56
2.26
1.6
1.4
—
—
—
0
0
49
319
1.56
2.26
1.6
1.4
7.4
7.6
g/l
0.19
35
240
49
319
1.56
2.26
1.6
1.4
4.0
3.9
g/l
0.13
35
232
365
3216
1.21
2.24
2.2
2.2
77.7
78.8
nmol/l
0.30
327
2815
28
157
1.81
2.23
1.5
1.3
—
—
—
0
0
418
3734
1.21
2.22
5.8
5.0
0.0
0.0
estimate
0.00
70
639
105
795
1.36
2.22
2.4
2.5
5.6
7.2
ug/l
0.68
93
691
295
2550
1.22
2.18
2.4
2.1
205.1
237.1
u/l
0.30
272
2392
192
1587
1.26
2.14
4.6
4.0
261.5
407.6
ng/l
0.67
159
1301
794
7560
1.25
2.12
19.3
12.9
26.3
23.7
mg/l
1.26
660
5901
21
109
1.95
2.11
1.2
1.2
—
17.3
—
0
5
20
104
1.94
2.01
1.3
1.3
9.5
10.1
u/l
0.08
13
83
45
297
1.54
1.98
1.5
1.4
8.7
10.6
g/l
3.00
39
254
125
989
1.30
1.97
1.4
1.4
—
—
—
0
0
414
3725
1.19
1.97
4.3
3.7
0.0
0.0
estimate
0.00
69
641
28
164
1.73
1.96
1.7
1.5
—
—
—
0
0
36
226
1.62
1.96
3.2
3.3
—
—
—
0
0
30
181
1.68
1.90
5.6
2.8
7.3
7.7
mmol/l
0.23
30
175
9
34
2.66
1.86
1.4
1.4
—
—
—
0
0
236
2026
1.22
1.85
2.7
2.4
13124.7
6325.4
umol/l
0.62
206
1723
14
66
2.14
1.82
5.5
2.2
—
—
—
0
0
44
296
1.51
1.80
1.6
1.4
3.1
3.1
g/l
0.02
35
234
7
23
3.06
1.80
2.9
4.2
—
—
—
0
0
14
67
2.11
1.76
2.2
2.1
2.2
1.7
u/field
—
5
26
14
67
2.11
1.76
1.1
1.2
—
—
—
0
0
16
81
1.99
1.75
1.4
1.3
—
—
—
0
0
6
18
3.35
1.75
1.0
1.1
18.7
15.2
pmol/l
—
6
12
31
194
1.62
1.73
5.5
2.7
1.7
1.6
mmol/l
0.09
31
188
19
103
1.86
1.72
1.1
1.4
—
—
—
0
0
611
5722
1.18
1.72
4.6
4.1
14.5
12.5
mm/h
2.09
565
5236
15
75
2.02
1.70
1.2
1.1
—
—
—
0
0
80
1038
0.75
1.69
5.0
4.9
32.8
33.0
%
0.06
47
695
182
1544
1.22
1.60
1.2
1.2
1.0
1.5
u/ml
0.85
41
407
8
32
2.51
1.60
1.0
1.4
—
—
—
0
0
8
32
2.51
1.60
1.0
1.4
—
—
—
0
0
8
32
2.51
1.60
1.1
1.3
—
—
—
0
0
24
144
1.68
1.58
1.1
1.5
—
—
—
0
0
15
78
1.94
1.54
1.3
1.3
—
—
—
0
0
748
7152
1.19
1.53
17.6
11.8
76.3
76.5
ml/min/173m2
0.10
638
5759
27
169
1.61
1.53
2.2
2.2
131.5
131.8
g/l
0.02
22
129
15
79
1.91
1.50
1.3
1.3
—
—
—
0
0
15
79
1.91
1.50
1.4
1.3
—
—
—
0
0
382
3479
1.16
1.47
2.2
2.1
93.9
94.5
pmol/l
0.09
210
1742
321
2886
1.17
1.46
4.8
3.9
—
—
—
0
0
7
28
2.51
1.45
1.1
1.1
—
—
—
0
0
350
3170
1.16
1.45
4.7
3.8
41.7
52.5
ng/l
0.39
255
2281
30
196
1.55
1.44
1.3
1.4
263.5
308.7
ug/g
0.75
21
118
15
81
1.86
1.40
1.4
1.3
—
—
—
0
0
15
81
1.86
1.40
1.4
1.3
—
—
—
0
0
18
104
1.74
1.37
1.1
1.4
69.3
69.7
%
—
8
64
32
216
1.50
1.34
1.2
1.2
—
—
—
0
0
224
1970
1.18
1.34
2.8
2.2
3.3
2.9
mg/l
1.22
199
1670
0
40
0.00
1.33
0.0
1.1
—
—
—
0
0
24
152
1.59
1.32
1.1
1.4
—
—
—
0
0
231
2040
1.17
1.31
4.6
3.8
22.5
24.2
%
1.01
110
971
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
10
49
2.05
1.22
1.1
1.2
—
—
—
0
0
16
93
1.73
1.21
2.1
1.8
87.9
89.8
%
0.48
16
93
30
205
1.48
1.21
2.4
1.6
—
—
—
0
0
52
394
1.34
1.18
2.3
2.2
10.0
14.8
nmol/l
4.73
47
342
226
2010
1.16
1.18
5.0
4.0
0.0
0.0
estimate
0.69
63
623
90
735
1.25
1.17
1.6
1.7
1.5
1.5
%
0.16
80
618
163
1413
1.18
1.16
2.9
2.7
0.8
0.7
ug/l
0.17
109
960
19
118
1.62
1.15
5.9
3.6
56.6
58.7
%
0.36
19
118
24
160
1.51
1.10
1.1
1.1
—
—
—
0
0
8
41
1.96
1.09
1.0
1.3
—
—
—
0
0
7
32
2.20
1.08
3.1
3.3
1482.1
1156.3
u/ml
—
7
32
15
89
1.70
1.08
1.1
1.5
—
—
—
0
0
115
975
1.20
1.06
1.4
1.4
—
—
—
0
0
29
203
1.44
1.06
1.2
1.1
—
—
—
0
0
181
1598
1.16
1.04
1.6
1.6
1.4
1.3
mg/l
0.20
136
1226
29
204
1.43
1.04
1.2
1.1
—
—
—
0
0
620
5924
1.12
1.02
4.5
4.0
15.1
14.9
pmol/l
0.64
552
5359
288
2634
1.13
1.00
3.1
3.1
7.0
7.3
mmol/l
0.53
235
2216
18
115
1.58
1.00
5.1
3.3
4.1
4.4
e9/l
0.22
18
115
57
451
1.28
0.99
1.5
1.5
—
—
—
0
0
41
310
1.34
0.98
1.0
1.0
—
—
—
0
0
7
36
1.95
0.97
2.1
1.4
—
—
—
0
0
7
36
1.95
0.97
1.7
1.4
—
—
—
0
0
7
36
1.95
0.97
1.7
1.4
—
—
—
0
0
296
2717
1.13
0.97
4.0
3.9
10.5
9.1
mg/mmol
0.19
181
1706
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
12
70
1.72
0.93
1.0
1.6
—
—
—
0
0
9
52
1.74
0.92
1.0
1.5
—
—
—
0
0
16
102
1.58
0.91
1.2
1.3
—
—
—
0
0
822
8017
1.15
0.89
21.6
15.6
139.7
139.8
mmol/l
0.39
804
7781
148
1304
1.16
0.89
1.3
1.3
28.6
37.3
iu/ml
0.68
58
404
5
104
0.48
0.89
1.0
1.0
—
—
—
0
0
27
194
1.40
0.89
2.0
3.5
0.7
0.8
nmol/l
0.28
18
154
8
43
1.87
0.87
2.8
2.7
—
—
—
0
0
824
8043
1.14
0.86
22.0
15.7
4.0
4.0
mmol/l
1.14
805
7792
275
2531
1.12
0.86
4.9
3.9
2.7
2.1
ug/l
0.70
241
2251
492
4672
1.11
0.85
3.3
3.0
59.9
46.6
u/l
1.46
455
4291
14
88
1.60
0.84
1.2
1.4
—
—
—
0
0
30
222
1.36
0.84
1.3
1.7
1.2
1.2
g/l
0.65
30
213
192
1734
1.13
0.82
5.1
4.1
1.0
1.0
kg/l
0.26
22
257
29
215
1.36
0.81
1.3
1.7
0.3
0.2
g/l
0.69
29
208
143
1267
1.15
0.81
2.0
1.8
—
—
—
0
0
21
147
1.44
0.80
1.3
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
16
106
1.52
0.79
1.4
1.2
0.7
0.7
nmol/l
0.11
16
98
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
29
217
1.35
0.77
2.7
2.2
88.4
74.5
ug/min
0.13
19
126
6
34
1.77
0.76
1.0
1.3
—
—
—
0
0
6
34
1.77
0.76
1.0
1.3
—
—
—
0
0
87
746
1.18
0.75
2.8
2.2
4.7
7.6
umol/l
3.91
75
638
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
89
768
1.17
0.72
2.8
3.2
289.8
227.3
ng/l
0.42
76
711
9
56
1.61
0.72
1.3
1.1
—
—
—
0
0
9
56
1.61
0.72
1.3
1.1
—
—
—
0
0
9
56
1.61
0.72
1.3
1.1
—
—
—
0
0
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
14
93
1.51
0.69
1.2
1.3
—
—
—
0
0
19
135
1.42
0.69
2.0
1.7
—
—
—
0
0
11
69
1.60
0.68
1.1
1.2
2.2
1.4
nmol/l
1.17
11
58
5
27
1.86
0.68
1.0
1.2
232.6
216.0
iu/ml
—
5
27
827
8109
1.12
0.65
12.3
9.1
25.2
25.1
u/l
0.05
796
7744
11
70
1.58
0.65
1.2
1.4
—
—
—
0
0
102
902
1.15
0.62
1.9
1.7
—
—
—
0
0
102
905
1.14
0.60
1.9
1.8
—
—
—
0
0
75
652
1.16
0.58
2.3
1.8
355.5
366.1
nmol/l
0.15
65
590
217
2016
1.10
0.58
1.6
1.6
20.9
20.9
nmol/l
0.01
187
1692
427
4084
1.08
0.57
2.6
2.6
—
—
—
0
0
11
73
1.51
0.56
1.5
1.1
—
80.9
—
0
9
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
37
1.63
0.55
1.0
1.2
—
—
—
0
0
6
38
1.58
0.54
1.3
1.2
130.8
76.9
u/l
—
6
31
6
38
1.58
0.54
1.0
2.2
15.5
18.6
nmol/l
—
6
31
9
61
1.48
0.53
1.3
1.6
—
—
—
0
0
9
62
1.46
0.53
1.2
1.4
—
—
—
0
0
730
7140
1.08
0.53
5.4
4.8
2.0
2.1
mu/l
0.51
667
6474
16
117
1.37
0.52
1.2
1.4
—
—
—
0
0
37
308
1.21
0.48
2.1
1.6
—
—
—
0
0
169
1819
0.91
0.48
1.7
1.7
462.1
13893050.3
pmol/l
1.32
144
1490
12
85
1.42
0.47
3.6
3.4
—
—
—
0
0
7
49
1.43
0.46
2.0
1.6
—
—
—
0
0
28
228
1.23
0.45
1.4
1.3
—
—
—
0
0
115
1055
1.10
0.42
8.5
7.0
—
—
—
0
0
202
2143
0.93
0.41
1.5
1.7
1.4
1.4
mmol/l
0.24
164
1778
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.47
0.40
1.0
1.3
—
—
—
0
0
5
36
1.39
0.38
2.4
2.3
—
—
—
0
0
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
6
44
1.37
0.34
1.0
1.0
—
—
—
0
0
50
445
1.13
0.33
1.3
1.2
80.0
123.4
iu/ml
0.91
15
181
852
8430
1.08
0.32
28.2
19.2
132.7
135.1
g/l
4.73
841
8259
7
53
1.32
0.31
1.9
2.1
—
113.6
—
0
14
22
184
1.20
0.30
1.3
1.7
—
—
—
0
0
23
194
1.19
0.29
1.1
1.3
440.8
500.6
mg/l
0.82
23
185
176
1674
1.06
0.29
1.8
1.8
1167.9
1171.1
nmol/l
0.01
136
1267
24
204
1.18
0.29
1.3
1.4
—
—
—
0
0
43
480
0.89
0.28
2.1
1.6
—
—
—
0
0
14
113
1.24
0.26
1.0
1.1
—
—
—
0
0
5
71
0.70
0.26
1.8
1.5
—
—
—
0
0
10
77
1.30
0.26
1.1
1.0
2.2
2.8
u/ml
—
5
26
268
2588
1.05
0.26
3.9
3.0
1816.4
1512.8
ng/l
0.44
225
2198
5
74
0.67
0.26
1.2
1.1
—
—
—
0
0
9
72
1.25
0.25
1.0
1.1
—
—
—
0
0
7
93
0.75
0.22
1.3
2.7
—
26.9
—
0
19
10
79
1.27
0.22
1.3
1.1
0.1
0.8
u/ml
—
5
29
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
11
89
1.24
0.21
1.1
1.1
—
—
—
0
0
28
249
1.13
0.21
1.3
2.1
—
—
—
0
0
9
115
0.78
0.20
2.0
1.4
—
—
—
0
0
728
7354
0.96
0.20
4.4
4.2
1.3
1.3
mmol/l
1.30
646
6652
35
317
1.11
0.20
1.3
1.3
—
—
—
0
0
6
51
1.18
0.19
2.3
1.5
—
—
—
0
0
7
58
1.21
0.18
2.3
1.8
—
—
—
0
0
55
513
1.08
0.18
2.1
1.8
—
—
—
0
0
17
148
1.15
0.17
1.3
1.7
—
—
—
0
0
7
90
0.78
0.14
1.1
1.1
—
—
—
0
0
45
422
1.07
0.13
1.8
1.8
—
—
—
0
0
40
374
1.07
0.13
1.6
1.7
—
—
—
0
0
741
7360
1.03
0.12
7.2
6.2
40.7
40.4
mmol/mol
0.37
678
6781
20
181
1.11
0.12
1.2
1.8
1.3
4.9
iu/l
—
6
62
19
209
0.91
0.11
1.1
1.4
—
—
—
0
0
5
47
1.06
0.09
2.2
1.5
—
—
—
0
0
770
7661
1.02
0.09
5.3
4.9
6.2
6.0
mmol/l
1.62
692
6931
763
7668
0.98
0.09
4.9
4.7
4.6
4.6
mmol/l
0.23
691
7044
11
124
0.89
0.09
2.0
1.5
—
—
—
0
0
781
7844
0.98
0.08
5.6
5.3
2.7
2.7
mmol/l
0.25
711
7172
5
65
0.77
0.08
1.6
1.5
—
—
—
0
0
5
65
0.77
0.08
1.6
1.5
—
—
—
0
0
5
65
0.77
0.08
1.6
1.5
—
—
—
0
0
22
205
1.07
0.08
1.8
1.6
—
—
—
0
0
27
258
1.05
0.04
2.1
1.9
2.6
4.8
mg/l
0.50
20
195
30
288
1.04
0.04
2.2
1.6
—
—
—
0
0
12
113
1.06
0.02
1.1
1.2
—
—
—
0
0
761
7603
1.00
0.00
4.8
4.7
1.4
1.5
mmol/l
1.50
686
6940
15
146
1.03
0.00
1.2
1.3
—
—
—
0
0
16
158
1.01
0.00
1.6
1.4
—
—
—
0
0
16
158
1.01
0.00
1.6
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
14.5
—
0
5
6
60
1.00
0.00
1.3
1.6
—
—
—
0
0
8
83
0.96
0.00
1.0
1.0
1.6
1.5
g/l
—
8
74
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
126
1260
1.00
0.00
1.3
1.3
5.0
12.8
u/ml
1.68
48
480
5
57
0.88
0.00
1.2
1.4
—
55.0
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
18
180
1.00
0.00
3.4
3.5
19.9
26.7
mg/l
0.35
12
119
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SALIVARY_NOS_EXALLC – Benign neoplasm: other/unspecified salivary gland
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).